Hosted on MSN2mon
Vifor Pharma offers £23m to NHS to resolve CMA investigationThe UK’s Competition and Markets Authority (CMA) has received a £23m ($29m) offer from Vifor Pharma for the NHS to address competition concerns that the regulator has been investigating.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback